Mixed chimerism and graft-versus-tumor effect - A curative concept derived from the dog model

被引：0
|
作者：
Storb, RF
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：80 / 80
页数：1
相关论文
共 50 条
  • [21] Role of Glucose Transporter 1 in Graft-Versus-Host Disease and Graft-Versus-Tumor Effect
    Huang, Ying
    Jiao, Yiqun
    Shi, Peijie
    Nie, Xiaoli
    Huang, Wei
    Choi, Michael
    Macintyre, Andrew N.
    Nichols, Amanda
    MacIver, Nancie J.
    Chao, Nelson J.
    Rathmell, Jeffrey
    Chen, Benny J.
    BLOOD, 2017, 130
  • [22] May primary liver cancer induce a graft-versus-tumor effect?
    A Sirvent-von Bueltzingsloewen
    N Gratecos
    J G Fuzibet
    J P Cassuto
    Bone Marrow Transplantation, 2003, 31 : 317 - 318
  • [23] Allogeneic Immunotherapy to Optimize the Graft-versus-Tumor Effect: Concepts and Controversies
    Porter, David L.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2011, : 292 - 298
  • [24] May primary liver cancer induce a graft-versus-tumor effect?
    Sirvent-von Bueltzingsloewen, A
    Gratecos, N
    Fuzibet, JG
    Cassuto, J
    BONE MARROW TRANSPLANTATION, 2003, 31 (04) : 317 - 318
  • [25] Graft-versus-tumor effect in murine hepatoma model and hepatocyto growth factor suppress graft-versus-host disease.
    Yoshida, Y
    Hirano, T
    Iimuro, Y
    Fujimoto, J
    HEPATOLOGY, 2004, 40 (04) : 521A - 521A
  • [26] Vaccine induced graft-versus-tumor effects are separable from graft-versus-host disease.
    Teshima, T
    Mach, N
    Hill, GR
    Dranoff, G
    Ferrara, JLM
    BLOOD, 1999, 94 (10) : 635A - 635A
  • [27] Allogeneic versus syngeneic killer splenocytes as effector cells for the induction of graft-versus-tumor effect
    Morecki, S
    Yacovlev, E
    Gelfand, Y
    Vilensky, A
    Slavin, S
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (01) : 40 - 48
  • [28] TRAIL receptors expression affect graft-versus-tumor (GVT) effect against gastrointestinal tumor
    Tateishi, K
    Ohta, M
    Guleng, B
    Ijichi, H
    Tanaka, Y
    Imamura, J
    Imamura, T
    Ikenoue, T
    Fukushima, Y
    Kawakami, T
    Amarsanaa, J
    Kanai, F
    Kawabe, T
    Omata, M
    GASTROENTEROLOGY, 2004, 126 (04) : A389 - A390
  • [29] Graft-Versus-Tumor Effect In Patients with Graft-Versus-Host Disease Defined by NIH Consensus Criteria.
    Lee, Sung-Eun
    Cho, Byung-Sik
    Yahng, Seung-Ah
    Eom, Ki-Seong
    Kim, Yoo-Jin
    Kim, Hee-Je
    Lee, Seok
    Min, Chang-Ki
    Cho, Seok-Goo
    Kim, Dong-Wook
    Lee, Jong-Wook
    Min, Woo-Sung
    Park, Chong-Won
    BLOOD, 2010, 116 (21) : 968 - 968
  • [30] High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses
    Mossoba, Miriam E.
    Halverson, David C.
    Kurlander, Roger
    Schuver, Bazetta Blacklock
    Carpenter, Ashley
    Hansen, Brenna
    Steinberg, Seth M.
    Ali, Syed Abbas
    Tageja, Nishant
    Hakim, Frances T.
    Gea-Banacloche, Juan
    Sportes, Claude
    Hardy, Nancy M.
    Hickstein, Dennis D.
    Pavletic, Steven Z.
    Khuu, Hanh
    Sabatini, Marianna
    Stroncek, David
    Levine, Bruce L.
    June, Carl H.
    Mariotti, Jacopo
    Rixe, Olivier
    Fojo, Antonio Tito
    Bishop, Michael R.
    Gress, Ronald E.
    Fowler, Daniel H.
    CLINICAL CANCER RESEARCH, 2015, 21 (19) : 4312 - 4320
12345